Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects
暂无分享,去创建一个
Yi Ai | Richard Grondin | G. Gerhardt | W. Markesbery | Zhiming Zhang | R. Grondin | D. Gash | Y. Ai | Zhiming Zhang | William Markesbery | Dennis Elseberry | Greg A. Gerhardt | Don M. Gash | Dennis Elseberry
[1] J. van Hattum,et al. Zinc therapy as the initial treatment for Wilson's disease. , 1988, Archives of neurology.
[2] L. Olson,et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. , 1991, Archives of neurology.
[3] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[4] Mark J. West,et al. New stereological methods for counting neurons , 1993, Neurobiology of Aging.
[5] G. M. Halliday,et al. Practical considerations for the use of the optical disector in estimating neuronal number , 1994, Journal of Neuroscience Methods.
[6] E. Arenas,et al. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo , 1995, Neuron.
[7] W. Mark Saltzman,et al. Distribution of nerve growth factor following direct delivery to brain interstitium , 1995, Brain Research.
[8] L Li,et al. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Oppenheim,et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.
[10] B J Hoffer,et al. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys , 1995, The Journal of comparative neurology.
[11] R. Penn,et al. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: Distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons , 1996, Neuroscience.
[12] B. Hoffer,et al. Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.
[13] A. Buj-Bello,et al. Characterization of a multicomponent receptor for GDNF , 1996, Nature.
[14] B. Ponder,et al. GDNF signalling through the Ret receptor tyrosine kinase , 1996, Nature.
[15] N. Belluardo,et al. Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.
[16] L. Olson,et al. Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs , 1997, Experimental Brain Research.
[17] Zhiming Zhang,et al. Neuroprotective and neurorestorative properties of GDNF , 1998, Annals of neurology.
[18] G. Glazner,et al. Localization of glial cell line‐derived neurotrophic factor receptor alpha and c‐ret mRNA in rat central nervous system , 1998, The Journal of comparative neurology.
[19] A. Toga,et al. The Rhesus Monkey Brain in Stereotaxic Coordinates , 1999 .
[20] R. Killiany,et al. Age-related neuronal loss from the substantia nigra-pars compacta and ventral tegmental area of the rhesus monkey. , 1999, Journal of neuropathology and experimental neurology.
[21] W. Saltzman,et al. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Davidson,et al. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat , 1999, Gene Therapy.
[23] L. Olson,et al. GFRα-1 is expressed in parvalbumin GABAergic neurons in the hippocampus , 2000, Brain Research.
[24] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[25] G. Gerhardt,et al. Long-term infusion of nonphysiologic solutions into brain parenchyma: effects of pH, osmolarity, and flow rate. , 2000, Comparative medicine.
[26] K J Burchiel,et al. DBS and diathermy interaction induces severe CNS damage , 2001, Neurology.
[27] G. Gerhardt,et al. Chronic Intracerebral Delivery of Trophic Factors via a Programmable Pump as a Treatment for Parkinsonism. , 2001, Methods in molecular medicine.
[28] L. Olson,et al. GFRα‐1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area , 2001 .
[29] W. Frey,et al. Delivery of Neurotrophic Factors to the Central Nervous System , 2001, Clinical pharmacokinetics.
[30] P. Aebischer,et al. Sustained delivery of GDNF: towards a treatment for Parkinson’s disease , 2001, Brain Research Reviews.
[31] G. Gerhardt,et al. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys , 2002, Neurobiology of Aging.
[32] R. Bakay,et al. Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration , 2002, The Journal of Neuroscience.
[33] Richard Grondin,et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. , 2002, Brain : a journal of neurology.
[34] R. Segal,et al. Location, location, location: a spatial view of neurotrophin signal transduction , 2002, Trends in Neurosciences.